Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for ...

Following a sharp rally in the previous session, Teladoc Health (NYSE:TDOC) added ~5% in the premarket on Tuesday after ...

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential ...

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...

Citron Research described Teladoc as a "coiled spring," noting that despite being the world’s largest telehealth platform with a market capitalization of just $1.2 billion, it owns BetterHelp, which ...

Stellantis has enforced an immediate stop-drive action across Europe for specific models of Citroën C3 and DS3 vehicles.

Technical Fouls: None. Percentages: FG .492, FT .692. 3-Point Goals: 3-10, .300 (Van Lith 1-1, Allen 1-2, Nurse 1-2, Atkins 0-1, Onyenwere 0-1, Reese 0-1, Banham 0-2).

Last week, Citron Research made a splash after it labeled Teladoc Health (NYSE: TDOC) a hidden artificial intelligence (AI) opportunity that is still viewed by many as a "pandemic relic." ...

Citron Research, through its X social media account, projected a potential $60 share price for Nebius, based on what it called “napkin math” assuming a 50% discount to CoreWeave’s multiple.

(Bloomberg) -- MicroStrategy Inc shares tumbled after Andrew Left’s Citron Research said in a post on X that it’s betting against the software company, which has effectively transformed itself into a ...

Investing.com -- Citron Research has voiced concerns over MicroStrategy's current valuation, even as the software company's shares have seen exponential growth fueled by its Bitcoin strategy.. In ...